Andreia C Lino
Overview
Explore the profile of Andreia C Lino including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
1766
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rincon-Arevalo H, Stefanski A, Le T, Cases M, Wiedemann A, Szelinski F, et al.
Front Immunol
. 2024 Jul;
15:1432045.
PMID: 39050849
Memory B cells (mBCs) are characterized by their long-term stability, fast reactivation, and capability to rapidly differentiate into antibody-secreting cells (ASCs). However, the role of T cells in the differentiation...
2.
Stefanski A, Rincon-Arevalo H, Dressler-Steinbach I, Nomovi N, Mackert A, Aue A, et al.
Ann Rheum Dis
. 2024 Jul;
83(11):1598-1600.
PMID: 38997131
No abstract available.
3.
Ritter J, Szelinski F, Aue A, Stefanski A, Rincon-Arevalo H, Chen Y, et al.
J Autoimmun
. 2024 May;
147:103243.
PMID: 38788537
Objectives: Autoreactive B cells and interferon (IFN) signature are hallmarks of primary sjögren's syndrome (pSS), but how IFN signaling pathways influence autoantibody production and clinical manifestations remain unclear. More detailed...
4.
Ferreira-Gomes M, Chen Y, Durek P, Rincon-Arevalo H, Heinrich F, Bauer L, et al.
Nat Commun
. 2024 May;
15(1):4182.
PMID: 38755157
Bone marrow plasma cells (BMPC) are the correlate of humoral immunity, consistently releasing antibodies into the bloodstream. It remains unclear if BMPC reflect different activation environments or maturation of their...
5.
Le T, Chu V, Lino A, Schrezenmeier E, Kressler C, Hamo D, et al.
Mol Ther Nucleic Acids
. 2022 Dec;
30:621-632.
PMID: 36514352
Human B lymphocytes are attractive targets for immunotherapies in autoantibody-mediated diseases. Gene editing technologies could provide a powerful tool to determine gene regulatory networks regulating B cell differentiation into plasma...
6.
Stefanski A, Rincon-Arevalo H, Schrezenmeier E, Karberg K, Szelinski F, Ritter J, et al.
Front Immunol
. 2022 Aug;
13:943476.
PMID: 36032111
Background: Durable vaccine-mediated immunity relies on the generation of long-lived plasma cells and memory B cells (MBCs), differentiating upon germinal center (GC) reactions. SARS-CoV-2 mRNA vaccination induces a strong GC...
7.
Stefanski A, Rincon-Arevalo H, Schrezenmeier E, Karberg K, Szelinski F, Ritter J, et al.
Front Immunol
. 2022 May;
13:822885.
PMID: 35514962
Background: Vaccination is considered as most efficient strategy in controlling SARS-CoV-2 pandemic spread. Nevertheless, patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) are at increased risk to fail humoral...
8.
Szelinski F, Stefanski A, Schrezenmeier E, Rincon-Arevalo H, Wiedemann A, Reiter K, et al.
Arthritis Rheumatol
. 2022 May;
74(9):1556-1568.
PMID: 35507291
Objective: Altered composition of the B cell compartment in the pathogenesis of systemic lupus erythematosus (SLE) is characterized by expanded plasmablast and IgD-CD27- double-negative B cell populations. Previous studies showed...
9.
Dang V, Mohr E, Szelinski F, Le T, Ritter J, Hinnenthal T, et al.
Front Immunol
. 2022 Apr;
13:873217.
PMID: 35464469
Antibody-secreting cells (ASCs) contribute to immunity through production of antibodies and cytokines. Identification of specific markers of ASC would allow selective targeting of these cells in several disease contexts. Here,...
10.
Stefanski A, Rincon-Arevalo H, Schrezenmeier E, Karberg K, Szelinski F, Ritter J, et al.
Arthritis Rheumatol
. 2021 Dec;
74(6):934-947.
PMID: 34962360
Objective: Patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX) therapy are at higher risk of poor COVID-19 outcomes and show substantially impaired humoral immune response to anti-SARS-CoV-2 vaccine. However,...